Literature DB >> 28778376

Pharmacological Therapy for Rate and Rhythm Control for Atrial Fibrillation in 2017.

Logan Kanagaratnam1, Peter Kowey2, David Whalley3.   

Abstract

In spite of the emergence of non-pharmacological approaches, medical therapy remains the primary modality of treatment for most patients with atrial fibrillation (AF). This review will look at evidence for rate and rhythm control approaches, and at factors that would help in choosing the appropriate treatment strategy for individual patients.
Copyright © 2017 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Atrial fibrillation; Pharmacological therapy

Mesh:

Substances:

Year:  2017        PMID: 28778376     DOI: 10.1016/j.hlc.2017.05.134

Source DB:  PubMed          Journal:  Heart Lung Circ        ISSN: 1443-9506            Impact factor:   2.975


  2 in total

Review 1.  Mechanisms and Drug Development in Atrial Fibrillation.

Authors:  David Calvo; David Filgueiras-Rama; José Jalife
Journal:  Pharmacol Rev       Date:  2018-07       Impact factor: 25.468

2.  Optimal antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: A systemic review and meta-analysis.

Authors:  Jing-Xiu Li; Yang Li; Shu-Jun Yan; Bai-He Han; Zhao-Yan Song; Wei Song; Shi-Hao Liu; Ji-Wei Guo; Shuo Yin; Ye-Ping Chen; De-Jun Xia; Xin Li; Xue-Qi Li; En-Ze Jin
Journal:  Biomed Rep       Date:  2017-12-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.